HEPA
Vanguard Group’s Hepion Pharmaceuticals HEPA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,251
| Closed | -$23.6K | – | 4287 |
|
|
2024
Q4 | $23.6K | Sell |
50,251
-40,671
| -45% | -$19.1K | ﹤0.01% | 4251 |
|
|
2024
Q3 | $60.9K | Sell |
90,922
-36,727
| -29% | -$24.6K | ﹤0.01% | 4234 |
|
|
2024
Q2 | $130K | Sell |
127,649
-29,711
| -19% | -$30.3K | ﹤0.01% | 4205 |
|
|
2024
Q1 | $392K | Sell |
157,360
-2,985
| -2% | -$7.43K | ﹤0.01% | 4069 |
|
|
2023
Q4 | $520K | Sell |
160,345
-5,167
| -3% | -$16.7K | ﹤0.01% | 4024 |
|
|
2023
Q3 | $826K | Hold |
165,512
| – | – | ﹤0.01% | 3902 |
|
|
2023
Q2 | $1.74M | Sell |
165,512
-3,144,668
| -95% | -$33M | ﹤0.01% | 3709 |
|
|
2023
Q1 | $2.57M | Hold |
3,310,180
| – | – | ﹤0.01% | 3585 |
|
|
2022
Q4 | $994K | Buy |
3,310,180
+1,657
| +0.1% | +$498 | ﹤0.01% | 3918 |
|
|
2022
Q3 | $1.67M | Hold |
3,308,523
| – | – | ﹤0.01% | 3818 |
|
|
2022
Q2 | $1.89M | Hold |
3,308,523
| – | – | ﹤0.01% | 3829 |
|
|
2022
Q1 | $4.27M | Sell |
3,308,523
-17,494
| -0.5% | -$22.6K | ﹤0.01% | 3610 |
|
|
2021
Q4 | $3.79M | Sell |
3,326,017
-4,724
| -0.1% | -$5.39K | ﹤0.01% | 3768 |
|
|
2021
Q3 | $5.1M | Hold |
3,330,741
| – | – | ﹤0.01% | 3648 |
|
|
2021
Q2 | $6.6M | Sell |
3,330,741
-455
| -0% | -$901 | ﹤0.01% | 3432 |
|
|
2021
Q1 | $6.13M | Buy |
3,331,196
+1,602,592
| +93% | +$2.95M | ﹤0.01% | 3420 |
|
|
2020
Q4 | $3.79M | Buy |
+1,728,604
| New | +$3.79M | ﹤0.01% | 3481 |
|
|
2019
Q2 | – | Sell |
-101,131
| Closed | -$23K | – | 4175 |
|
|
2019
Q1 | $23K | Hold |
101,131
| – | – | ﹤0.01% | 4097 |
|
|
2018
Q4 | $29K | Sell |
101,131
-224,444
| -69% | -$64.4K | ﹤0.01% | 4104 |
|
|
2018
Q3 | $183K | Buy |
325,575
+5,832
| +2% | +$3.28K | ﹤0.01% | 4010 |
|
|
2018
Q2 | $416K | Sell |
319,743
-2,270,870
| -88% | -$2.95M | ﹤0.01% | 3853 |
|
|
2018
Q1 | $596K | Hold |
2,590,613
| – | – | ﹤0.01% | 3751 |
|
|
2017
Q4 | $933K | Buy |
2,590,613
+107,029
| +4% | +$38.5K | ﹤0.01% | 3627 |
|
|
2017
Q3 | $1.29M | Buy |
2,483,584
+69,109
| +3% | +$35.9K | ﹤0.01% | 3523 |
|
|
2017
Q2 | $1.4M | Buy |
2,414,475
+366,192
| +18% | +$212K | ﹤0.01% | 3493 |
|
|
2017
Q1 | $3.63M | Buy |
2,048,283
+189,634
| +10% | +$336K | ﹤0.01% | 3176 |
|
|
2016
Q4 | $2.23M | Buy |
1,858,649
+934,265
| +101% | +$1.12M | ﹤0.01% | 3327 |
|
|
2016
Q3 | $989K | Buy |
924,384
+9,015
| +1% | +$9.65K | ﹤0.01% | 3574 |
|
|
2016
Q2 | $952K | Buy |
915,369
+73,135
| +9% | +$76.1K | ﹤0.01% | 3614 |
|
|
2016
Q1 | $1.02M | Buy |
842,234
+96,791
| +13% | +$117K | ﹤0.01% | 3596 |
|
|
2015
Q4 | $1.15M | Buy |
745,443
+210,900
| +39% | +$325K | ﹤0.01% | 3575 |
|
|
2015
Q3 | $1.12M | Buy |
534,543
+213,243
| +66% | +$446K | ﹤0.01% | 3598 |
|
|
2015
Q2 | $1.63M | Buy |
+321,300
| New | +$1.63M | ﹤0.01% | 3498 |
|